A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine

Update Il y a 4 ans
Reference: EUCTR2004-001363-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

1) To evaluate the efficacy of glufosfamide in subjects with metastatic pancreatic adenocarcinoma previously treated with gemcitabine as measured by overall survival compared with best supportive care 2) To evaluate the safety of glufosfamide in subjects with metastatic pancreatic adenocarcinoma previously treated with gemcitabine


Inclusion criteria

  • Previously treated metastatic pancreatic adenocarcinoma

Links